Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
0 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
December 21, 2025
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 20, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 24, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders
Classification
International Classes
005
016
044